Skip Navigation


Glycobiology Advance Access originally published online on May 7, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/8/67R    most recent
cwg077v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Martin, P. T.
Right arrow Articles by Freeze, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, P. T.
Right arrow Articles by Freeze, H. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2003, Vol. 13, No. 8 67R-75R
© 2003 Oxford University Press

REVIEW

Glycobiology of neuromuscular disorders

Paul T. Martin1,2 and Hudson H. Freeze3

2 Department of Neuroscience, Glycobiology Research and Training Center, University of California, San Diego, School of Medicine, La Jolla, CA 92093-0691
3 Glycobiology and Carbohydrate Chemistry Program, Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037

accepted on April 24, 2003

There has been a recent explosion in the identification of neuromuscular diseases caused by mutations in genes that affect carbohydrate metabolism or protein glycosylation. A number of these findings relate to defects in the glycosylation of {alpha} dystroglycan. {alpha} Dystroglycan is an essential component of the dystrophin–glycoprotein complex, and aberrant glycosylation of {alpha} dystroglycan is associated with multiple forms of muscular dystrophy in mice and humans. We review the evidence that defects in dystroglycan glycosylation cause muscular dystrophy. In addition, we review evidence that glycobiology is important in other disorders that affect muscle, including hereditary inclusion body myopathy type II and congenital disorders of glycosylation. Finally, we discuss the long-term potential of glycotherapies for muscle disorders.

1 To whom correspondence should be addressed; e-mail: pmartin{at}ucsd.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
R. Xu, K. Chandrasekharan, J. H. Yoon, M. Camboni, and P. T. Martin
Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A
Am. J. Pathol., July 1, 2007; 171(1): 181 - 199.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. S. Yatsenko, E. E. Gray, H. R. Shcherbata, L. B. Patterson, V. D. Sood, M. M. Kucherenko, D. Baker, and H. Ruohola-Baker
A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila
J. Biol. Chem., May 18, 2007; 282(20): 15159 - 15169.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
D. Lyalin, K. Koles, S. D. Roosendaal, E. Repnikova, L. Van Wechel, and V. M. Panin
The twisted Gene Encodes Drosophila Protein O-Mannosyltransferase 2 and Genetically Interacts With the rotated abdomen Gene Encoding Drosophila Protein O-Mannosyltransferase 1
Genetics, January 1, 2006; 172(1): 343 - 353.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
P. K. Grewal, J. M. McLaughlan, C. J. Moore, C. A. Browning, and J. E. Hewitt
Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies
Glycobiology, October 1, 2005; 15(10): 912 - 923.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Hong, S. Sundaram, D.-J. Shin, and P. Stanley
The Lec23 Chinese Hamster Ovary Mutant Is a Sensitive Host for Detecting Mutations in {alpha}-Glucosidase I That Give Rise to Congenital Disorder of Glycosylation IIb (CDG IIb)
J. Biol. Chem., November 26, 2004; 279(48): 49894 - 49901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Hoyte, V. Jayasinha, B. Xia, and P. T. Martin
Transgenic Overexpression of Dystroglycan Does Not Inhibit Muscular Dystrophy in mdx Mice
Am. J. Pathol., February 1, 2004; 164(2): 711 - 718.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.